The Cochrane Airways Group works with authors (typically clinicians and researchers) to produce systematic reviews on asthma, COPD, bronchiectasis and other lung diseases. Cochrane Airways was formed in 1995 and is based at St George’s University of London. We have published over 260 Cochrane Systematic Reviews and over 40 protocols.
The Cochrane Airways Group editorial team supports authors in writing and publishing their reviews. Systematic reviews aim to address a clinical question such as “Is giving reliever inhalers through a spacer as effective as delivering them through a nebuliser for people having an asthma attack?” The clinical question is considered carefully and a strategy prepared for answering that question – this is then written up into a ‘protocol’ and peer reviewed by experts and consumers before publication. Our information specialist provides a list of potentially useful randomised controlled trials for the author team to assess for inclusion. A review is prepared based on the relevant trials. The editorial team organises peer review to check that that the reviews are accurate and fair.
Cochrane Airways is a group of authors and editors that forms part of The Cochrane Collaboration. Cochrane is a not-for-profit, independent, global network of over 28,000 people working together to provide the best evidence for healthcare decisions. There are over 5,400 Cochrane Systematic reviews published on clinical questions ranging from pregnancy through to falls in the elderly; chemotherapy to yoga and many more.
The Cochrane Airways Group is part of the international Cochrane Collaboration, an independent not-for-profit consortium dedicated to providing up-to-date, accurate information about the effects of health care. The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Airways Group.
We are also grateful to St Georges University of London for support.
User guides Access options